ABSINasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Absci Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$8.54+0.29 (+3.52%)
Close on Oct 19, 2026
- Market cap
- $1.34B
- P/E (TTM)
- –
- Dividend yield
- –
Absci statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Services-Commercial Physical & Biological Research companies for comparison
Valuation
| Measure | Absci | Industry median |
|---|---|---|
| Market Cap | $1.47B | $74.60M |
| Enterprise Value | $1.26B | $56.72M |
| PS Ratio | 938.88 | 3.25 |
| PB Ratio | 5.95 | 3.13 |
| P/TBV Ratio | 7.11 | 8.30 |
Enterprise value
| Measure | Absci | Industry median |
|---|---|---|
| EV / Sales | 810.02 | 2.79 |
Income (trailing twelve months)
| Measure | Absci | Industry median |
|---|---|---|
| Revenue | $1.56M | $24.74M |
| Operating Income | -$126.20M | -$55.64K |
| Pretax Income | -$121.08M | $45.62K |
| Net Income | -$121.08M | -$97.64K |
| EBITDA | -$115.11M | -$29.48K |
| EPS (Diluted) | -$0.80 | $0.00 |
Margins
| Measure | Absci | Industry median |
|---|---|---|
| Operating Margin | -8084.5% | 0.94% |
| Pretax Margin | -7756.4% | 2.64% |
| Profit Margin | -7756.4% | 0.51% |
| EBITDA Margin | -7373.8% | 3.48% |
| FCF Margin | -6981.0% | 5.05% |
Returns
| Measure | Absci | Industry median |
|---|---|---|
| Return on Equity (ROE) | -57.7% | 0.45% |
| Return on Assets (ROA) | -50.6% | -3.47% |
| Return on Invested Capital (ROIC) | -122.2% | 2.85% |
| Return on Capital Employed (ROCE) | -50.6% | 2.03% |
Growth
| Measure | Absci | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -62.3% | 4.26% |
| Revenue Growth (3Y CAGR) | -21.3% | 2.15% |
| Revenue Growth (5Y CAGR) | -10.1% | 7.37% |
Balance sheet
| Measure | Absci | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $201.14M | $5.43M |
| Net Cash (Debt) | $201.14M | $17.62K |
| Net Cash Per Share | $1.17 | $0.00 |
| Equity (Book Value) | $246.13M | $10.50M |
| Book Value Per Share | $1.43 | $0.60 |
| Tangible Book Value | $206.08M | -$78.36K |
| Working Capital | $188.67M | $2.78M |
Financial position
| Measure | Absci | Industry median |
|---|---|---|
| Current Ratio | 10.63 | 1.26 |
| Quick Ratio | 10.26 | 0.65 |
| Interest Coverage | -1342.54 | -0.23 |
Cash flow (trailing twelve months)
| Measure | Absci | Industry median |
|---|---|---|
| Operating Cash Flow | -$108.08M | $8.04K |
| Capital Expenditures | -$890.00K | -$8.33M |
| Free Cash Flow | -$108.97M | $11.03M |
| FCF Per Share | -$0.63 | $0.76 |
Efficiency
| Measure | Absci | Industry median |
|---|---|---|
| Asset Turnover | 0.01 | 0.83 |
| Revenue Per Employee | $11.15K | $216.23K |
| Profits Per Employee | -$864.84K | -$3.19K |
| Employee Count | 140 | 123 |
Dividends and yields
| Measure | Absci | Industry median |
|---|---|---|
| Earnings Yield | -8.26% | -0.97% |
| FCF Yield | -7.44% | 3.90% |
| Buyback Yield | -11.6% | 1.36% |
| Shareholder Yield | -11.6% | 1.65% |
Shares
| Measure | Absci | Industry median |
|---|---|---|
| Shares Outstanding | 171,614,000 | 29,217,800 |
| Shares Change (YoY) | 25.9% | 0.84% |
| Float | 145,023,000 | 26,226,050 |
| Shares Held by Insiders | 15.5% | 4.85% |
| Shares Held by Institutions | 88.3% | 83.3% |
Taxes
| Measure | Absci | Industry median |
|---|---|---|
| Income Tax | $0 | $1.36M |
Scores
| Measure | Absci | Industry median |
|---|---|---|
| Altman Z-Score | 34.31 | 2.66 |
| Piotroski F-Score | 3 | 5 |
Calculated by StockData from Absci's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.